Transurethral volume reduction of the prostate (TUVOR)

US6491672B2 · kind B2 · utility

Assignee

• Harmonia Medical Technologies, Inc. · IL

Inventors

• Marvin J. Slepian · Tucson, US
• Daniel Yachia · Herzliya, IL
• Syed Hossainy · Hayward, US
• Baruch Levy · Rahat, IL
• Zeev Sohn · Or Yehuda, IL

Key dates

• Filing date: Feb 7, 2001
• Grant date: Dec 10, 2002
• Expiry date: May 17, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61B2018/00547
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

A process has been developed to reduce or relieve prostatic obstruction. The steps involved in the TUVOR Process include: 1. Transurethral Incision; 2. De-bulking and Intra-Prostatic Volume Reduction; 3. Intra-prostatic void exclusion and space filling with adhesive and/or therapeutic polymeric materials, alone or in combination with bioactive agents and/or mechanical means for closure; 4. Endourethral compression and prostatic mass remolding; 5. Endourethral Polymer Liner Layer. This liner formed from structurally supportive, yet eventually biodegradable, polymers further bolsters and supports the urethra and peri-urethral tissue during healing, eliminating the need for post-procedure catheter drainage. This step may be optional in specific clinical circumstances. The process is designed to allow outpatient treatment under local anesthesia for BPH.